Cold Atmospheric Plasma Treatment for Pancreatic Cancer–The Importance of Pancreatic Stellate Cells

Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease with low five-year survival rates of 8% by conventional treatment methods, e.g., chemotherapy, radiotherapy, and surgery. PDAC shows high resistance towards chemo- and radiotherapy and only 15–20% of all patients can have surgery. This dise...

Full description

Bibliographic Details
Main Authors: Ruben Verloy, Angela Privat-Maldonado, Evelien Smits, Annemie Bogaerts
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/12/10/2782
_version_ 1797552344190156800
author Ruben Verloy
Angela Privat-Maldonado
Evelien Smits
Annemie Bogaerts
author_facet Ruben Verloy
Angela Privat-Maldonado
Evelien Smits
Annemie Bogaerts
author_sort Ruben Verloy
collection DOAJ
description Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease with low five-year survival rates of 8% by conventional treatment methods, e.g., chemotherapy, radiotherapy, and surgery. PDAC shows high resistance towards chemo- and radiotherapy and only 15–20% of all patients can have surgery. This disease is predicted to become the third global leading cause of cancer death due to its significant rise in incidence. Therefore, the development of an alternative or combinational method is necessary to improve current approaches. Cold atmospheric plasma (CAP) treatments could offer multiple advantages to this emerging situation. The plasma-derived reactive species can induce oxidative damage and a cascade of intracellular signaling pathways, which could lead to cell death. Previous reports have shown that CAP treatment also influences cells in the tumor microenvironment, such as the pancreatic stellate cells (PSCs). These PSCs, when activated, play a crucial role in the propagation, growth and survival of PDAC tumors. However, the effect of CAP on PSCs is not yet fully understood. This review focuses on the application of CAP for PDAC treatment and the importance of PSCs in the response to treatment.
first_indexed 2024-03-10T15:59:42Z
format Article
id doaj.art-57695e03312a4f3b8f24b9da4734996d
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T15:59:42Z
publishDate 2020-09-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-57695e03312a4f3b8f24b9da4734996d2023-11-20T15:23:29ZengMDPI AGCancers2072-66942020-09-011210278210.3390/cancers12102782Cold Atmospheric Plasma Treatment for Pancreatic Cancer–The Importance of Pancreatic Stellate CellsRuben Verloy0Angela Privat-Maldonado1Evelien Smits2Annemie Bogaerts3Plasma Lab for Applications in Sustainability and Medicine-ANTwerp, University of Antwerp, 2610 Wilrijk, BelgiumPlasma Lab for Applications in Sustainability and Medicine-ANTwerp, University of Antwerp, 2610 Wilrijk, BelgiumCenter for Oncological Research, University of Antwerp, 2610 Wilrijk, BelgiumPlasma Lab for Applications in Sustainability and Medicine-ANTwerp, University of Antwerp, 2610 Wilrijk, BelgiumPancreatic ductal adenocarcinoma (PDAC) is a lethal disease with low five-year survival rates of 8% by conventional treatment methods, e.g., chemotherapy, radiotherapy, and surgery. PDAC shows high resistance towards chemo- and radiotherapy and only 15–20% of all patients can have surgery. This disease is predicted to become the third global leading cause of cancer death due to its significant rise in incidence. Therefore, the development of an alternative or combinational method is necessary to improve current approaches. Cold atmospheric plasma (CAP) treatments could offer multiple advantages to this emerging situation. The plasma-derived reactive species can induce oxidative damage and a cascade of intracellular signaling pathways, which could lead to cell death. Previous reports have shown that CAP treatment also influences cells in the tumor microenvironment, such as the pancreatic stellate cells (PSCs). These PSCs, when activated, play a crucial role in the propagation, growth and survival of PDAC tumors. However, the effect of CAP on PSCs is not yet fully understood. This review focuses on the application of CAP for PDAC treatment and the importance of PSCs in the response to treatment.https://www.mdpi.com/2072-6694/12/10/2782pancreatic cancerpancreatic ductal adenocarcinomapancreatic stellate cellscold atmospheric plasmatumor microenvironment
spellingShingle Ruben Verloy
Angela Privat-Maldonado
Evelien Smits
Annemie Bogaerts
Cold Atmospheric Plasma Treatment for Pancreatic Cancer–The Importance of Pancreatic Stellate Cells
Cancers
pancreatic cancer
pancreatic ductal adenocarcinoma
pancreatic stellate cells
cold atmospheric plasma
tumor microenvironment
title Cold Atmospheric Plasma Treatment for Pancreatic Cancer–The Importance of Pancreatic Stellate Cells
title_full Cold Atmospheric Plasma Treatment for Pancreatic Cancer–The Importance of Pancreatic Stellate Cells
title_fullStr Cold Atmospheric Plasma Treatment for Pancreatic Cancer–The Importance of Pancreatic Stellate Cells
title_full_unstemmed Cold Atmospheric Plasma Treatment for Pancreatic Cancer–The Importance of Pancreatic Stellate Cells
title_short Cold Atmospheric Plasma Treatment for Pancreatic Cancer–The Importance of Pancreatic Stellate Cells
title_sort cold atmospheric plasma treatment for pancreatic cancer the importance of pancreatic stellate cells
topic pancreatic cancer
pancreatic ductal adenocarcinoma
pancreatic stellate cells
cold atmospheric plasma
tumor microenvironment
url https://www.mdpi.com/2072-6694/12/10/2782
work_keys_str_mv AT rubenverloy coldatmosphericplasmatreatmentforpancreaticcancertheimportanceofpancreaticstellatecells
AT angelaprivatmaldonado coldatmosphericplasmatreatmentforpancreaticcancertheimportanceofpancreaticstellatecells
AT eveliensmits coldatmosphericplasmatreatmentforpancreaticcancertheimportanceofpancreaticstellatecells
AT annemiebogaerts coldatmosphericplasmatreatmentforpancreaticcancertheimportanceofpancreaticstellatecells